Evotec
Nazia Hassan is a seasoned IT Business Analyst with extensive experience in project management and business analysis. Currently serving as a Senior IT Business Analyst at Evotec since December 2022, Nazia previously held pivotal roles at Telenor Global Shared Services, where significant improvements in customer service NPS were achieved. Earlier positions include Business Analyst at Global Rescue LLC and LMKT, focusing on business process models and ERP solutions for Pakistan government entities. Nazia's career began as a Junior Software Engineer and progressed through various technical roles, establishing a robust background in software engineering and stakeholder management. Education includes a B.S. in Software Engineering from International Islamic University, Islamabad.
This person is not in the org chart
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.